Hofseth BioCare ASA announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was NOK 31.044 million compared to NOK 20.097 million a year ago. Operating loss was NOK 22.772 million compared to NOK 17.819 million a year ago. Net loss was NOK 24.638 million compared to NOK 20.275 million a year ago. Basic loss per share from continuing operations was NOK 0.07 compared to NOK 0.06 a year ago. For the half year, total revenue was NOK 47.879 million compared to NOK 38.621 million a year ago. Operating loss was NOK 47.805 million compared to NOK 33.808 million a year ago. Net loss was NOK 51.482 million compared to NOK 38.160 million a year ago. Basic loss per share from continuing operations was NOK 0.14 compared to NOK 0.12 a year ago.